For some people, migraine becomes newly erratic in the years before menopause. An attack that once arrived predictably with a period may appear in the middle of a cycle, or headaches may become more frequent just as bleeding becomes less regular. This is a real pattern, not proof that every midlife headache is hormonal. Perimenopause is a neuroendocrine transition, and migraine is a neurological disorder with many possible triggers. The useful question is not whether hormones are “to blame”, but what has changed, and what needs proper assessment.
A transition with an uneven timetable
Perimenopause is the interval leading up to menopause, when menstrual cycles and symptoms can change before periods stop altogether. The timing and experience vary substantially. The NHS list of menopause and perimenopause symptoms includes headaches and migraines that are worse than usual, alongside hot flushes, sleep disruption and changes in mood. That is recognition of a common clinical experience, not a diagnostic shortcut: a new or changed headache still merits its own history and examination.
The reason the association is plausible lies in variability. Oestrogen and progesterone do not simply decline in a smooth line during perimenopause; ovulation may become less predictable and hormone levels can fluctuate. Migraine biology is sensitive to that changing environment. A 2026 narrative review in Headache concluded that unstable estradiol and progesterone levels can make attacks less predictable during the transition, whilst also stressing that menopause-specific evidence remains limited.
Why a familiar pattern may stop being familiar
Menstrual migraine is already a clue that some brains respond to hormonal change. During perimenopause, the regularity of the cycle can disappear before menstruation does. That can make a previously recognisable window harder to spot. It can also coincide with disrupted sleep, vasomotor symptoms, stress, changes in alcohol use or altered eating patterns — all factors that may matter to an individual’s migraine pattern without being caused by the same mechanism.
This is where a diary can be more valuable than a theory. The NHS advises keeping a migraine diary to help identify possible triggers. Recording the date, duration, symptoms, aura if present, medication use, bleeding, sleep and hot flushes gives a clinician something concrete to work with. It does not establish cause. It may, however, reveal whether attacks are clustering around bleeding, poor sleep, missed meals, or a medication pattern that deserves attention.
What may happen after menopause
There is a tempting story that menopause solves migraine. It is too neat. The NHS says migraine often gets better after menopause, but “often” is not a prediction for an individual. The current Headache review describes a mixed and still incomplete evidence base across the transition. A change for the better is possible; persistent, changed or troublesome migraine is also a reason to discuss the pattern with a clinician rather than wait for a universal timetable.
The distinction between migraine with and without aura also matters. The NHS describes aura as temporary symptoms such as visual changes, tingling, dizziness or difficulty speaking. Contact a GP or NHS 111 urgently if aura symptoms last longer than one hour. No one should try to classify a new neurological symptom from an article.
Hormone therapy is not a migraine treatment by default
It is understandable to ask whether menopause hormone therapy will settle the hormonal swings and therefore the headaches. Sometimes changes in menopause symptoms and migraine occur together. But the evidence does not support treating hormone therapy as a universal migraine remedy. The 2026 Headache review describes variable effects of menopause hormone therapy on migraine and emphasises the limits of the available evidence. That uncertainty matters: an apparent hormonal explanation should not turn a prescribing decision into a promise of migraine prevention.
That does not mean hormone therapy is automatically off the table for a person with migraine. NICE recommends offering HRT for vasomotor symptoms associated with menopause, with decisions made in the context of symptoms, preferences, contraindications and risks. The indication is relief of menopause symptoms, not an internet promise to “balance hormones” or prevent migraine. Route, dose, whether a progestogen is needed, migraine subtype, smoking, blood pressure and vascular history can all change the conversation. Those choices belong with a qualified prescriber who knows the individual history.
Why aura changes the safety conversation
Migraine with aura deserves to be named explicitly in a consultation about hormones or contraception. The recent review discusses the vascular considerations around migraine, aura and exogenous hormones, but it cannot replace an individual assessment. Smoking, high blood pressure, diabetes, high cholesterol, age and the hormone preparation under consideration can alter the overall picture. This is one reason not to borrow advice from combined hormonal contraception and apply it wholesale to menopausal hormone therapy: they are different preparations, doses and clinical decisions.
The practical point is less dramatic and more useful. If aura is part of the history, say so explicitly when discussing contraception, HRT or a changed migraine pattern. A clinician can put that information alongside personal and family vascular history. The NHS advises calling 999 for a sudden and extremely painful headache; problems speaking or remembering; loss of vision, blurred vision or double vision; drowsiness or confusion; a seizure; a very high temperature and symptoms of meningitis; inability to move or weakness in the arms or legs on one side of the body, or on one side of the face; or a recent head injury. These symptoms should be treated as urgent medical concerns rather than assumed to be migraine.
Do not let “hormonal” obscure other explanations
Midlife is a period when several things can change at once. Blood pressure may rise, analgesic use can creep up, and new medicines can have headache as an adverse effect. Migraine itself can change. The NHS advises a GP review when attacks are severe, getting worse or lasting longer than usual, happening more than once a week, difficult to control, or regularly occurring before or during a period.
There is also a quieter problem: medication-overuse headache. The NHS cautions against taking painkillers on more than two days a week because this can lead to more headaches and make migraine harder to treat. That is not a reason to stop prescribed medicine abruptly. It is a reason to bring an honest list of all acute medication days to an appointment.
What this means in practice
- Keep a simple headache and symptom diary for several weeks, including bleeding, sleep, hot flushes, aura and every day you use acute medication.
- See a GP when attacks are severe, getting worse, lasting longer than usual, happening more than once a week, difficult to control, or regularly occurring before or during a period.
- When discussing HRT or contraception, mention migraine and be specific about whether you have ever had aura; do not assume a friend’s regimen is suitable for you.
- Ask for a review of blood pressure, smoking status and other vascular risk factors where relevant, especially if aura is part of the picture.
- Call 999 for a sudden and extremely painful headache; problems speaking or remembering; loss of vision, blurred vision or double vision; drowsiness or confusion; a seizure; a very high temperature and symptoms of meningitis; inability to move or weakness in the arms or legs on one side of the body, or on one side of the face; or a recent head injury.
What we don’t know
The central limitation is that relatively few high-quality studies follow people through the whole menopausal transition while separating migraine subtype, treatment route and background vascular risk. Much of the treatment literature is observational or based on specialist clinic populations. We therefore cannot predict from hormone levels, an FSH test or a single bad month whether an individual’s migraine will improve after menopause.
Nor can a symptom diary diagnose perimenopause or prove that a hormonal change caused an attack. It is a tool for noticing patterns and making a clinical conversation more precise. That distinction matters because the same symptom — a headache — can have benign, treatable and occasionally urgent explanations.
Perimenopause can make migraine feel less orderly because the underlying transition is less orderly. The evidence supports taking the pattern seriously, documenting it carefully and resisting one-size-fits-all hormone narratives. The goal is not to explain every attack with oestrogen; it is to make sure the right question reaches the right clinician.
Photo: George Milton on Pexels.